Prof. Uchiyama Stresses Need for Caution with Prazaxa Even at Low Dose

October 10, 2011
The Union of Risk Management for Preventive Medicine (URMPM) held a workshop on pharmaceutical safety management for healthcare professionals on September 17-18 in Tokyo. In a lecture on the direct thrombin inhibitor Prazaxa (dabigatran), Prof. Shinichiro Uchiyama of Tokyo Women’s...read more